Line Hagner Nielsen
Overview
Explore the profile of Line Hagner Nielsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lutta A, Liu Q, Pedersen G, Dong M, Grohganz H, Nielsen L, et al.
Drug Deliv Transl Res
. 2025 Feb;
PMID: 39987264
Polymer coating of nanoparticulate drug delivery systems may enhance the efficacy of oral delivery. Cationic liposomes were coated with pectin biopolymers using microfluidics, with systematic variation of process parameters to...
2.
Pantazoglou E, Tollemeto M, Ezazi N, Chang T, Hosta Rigau L, Jacobsen J, et al.
Mol Pharm
. 2024 Dec;
22(1):433-445.
PMID: 39690711
Buccal delivery offers a promising alternative to e.g., oral or parenteral drug administrations by leveraging the mucosal membranes of the mouth to enhance drug absorption and enhance patient compliance. Buccal...
3.
Tollemeto M, Ursulska S, Welzen P, Thamdrup L, Malakpour-Permlid A, Li Y, et al.
Small
. 2024 Jul;
20(43):e2403640.
PMID: 38963162
Ensuring precise drug release at target sites is crucial for effective treatment. Here, pH-responsive nanoparticles for oral administration of mycophenolate mofetil, an alternative therapy for patients with inflammatory bowel disease...
4.
Lutta A, Knopp M, Tollemeto M, Pedersen G, Schmidt S, Grohganz H, et al.
Int J Pharm
. 2024 Jan;
652:123798.
PMID: 38190949
Successful oral delivery of liposomes requires formulations designed to withstand harsh gastrointestinal conditions, e.g., by converting to solid-state followed by loading into gastro-resistant delivery devices. The hypothesis was that the...
5.
Bondegaard P, Torp A, Guerra P, Kristensen K, Christfort J, Krogfelt K, et al.
FEMS Microbiol Lett
. 2023 Oct;
370.
PMID: 37863838
For patients with ulcerative colitis (UC), administration of the probiotic E. coli Nissle (EcN) holds promise for alleviation of disease symptoms. The mechanisms are unclear, but it has been hypothesised...
6.
Zhao G, Zhao S, Nielsen L, Zhou F, Gu L, Tadesse B, et al.
Bioresour Technol
. 2023 Aug;
387:129594.
PMID: 37532060
The presence of lactic acid and galactose makes spray drying of acid whey (AW) a significant challenge for the dairy industry. In this study, a novel approach is explored to...
7.
Kamguyan K, Kjeldsen R, Zajforoushan Moghaddam S, Nielsen M, Thormann E, Zor K, et al.
Pharmaceutics
. 2022 Nov;
14(11).
PMID: 36432727
The biggest challenge in oral delivery of anti-inflammatory drugs such as 5-aminosalicylic acid (5-ASA) is to (i) prevent rapid absorption in the small intestine and (ii) achieve localized release at...
8.
Chang T, Kjeldsen R, Christfort J, Vila E, Alstrom T, Zor K, et al.
Adv Healthc Mater
. 2022 Nov;
12(4):e2201897.
PMID: 36414017
During the past decades, microdevices have been evaluated as a means to overcome challenges within oral drug delivery, thus improving bioavailability. Fabrication of microdevices is often limited to planar or...
9.
Carlsen P, Kjeldsen R, Pedersen G, Christensen D, Nielsen L, Boisen A
J Control Release
. 2022 Nov;
353:134-146.
PMID: 36372387
Oral vaccination has in the recent years gained a lot of attraction, mainly due to optimized patient compliance and logistics. However, the development of oral vaccines, especially oral subunit vaccines...
10.
Torp A, Kamguyan K, Christfort J, Kristensen K, Guerra P, Daniel N, et al.
Appl Environ Microbiol
. 2022 Jun;
88(14):e0073422.
PMID: 35758759
Oral antibiotic treatment is often applied in animal studies in order to allow establishment of an introduced antibiotic-resistant bacterium in the gut. Here, we compared the application of streptomycin dosed...